Overview: business performance in Q1 2025
| Q1 2025 (in € billion) | Change (in %, compared to Q1 2024) | Organic change (in %, compared to Q1 2024) |
|---|---|---|---|
Group net sales | 5.3 | 3.1 | 2.5 |
EBITDA pre | 1.5 | 5.6 | 5.8 |
Life Science sales | 2.2 | 3.5 | 2.5 |
Healthcare sales | 2.1 | 3.2 | 3.4 |
Electronics sales | 0.9 | 2.1 | 0.6 |